Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy

QR Code

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy

Mansing Ratanasukon, Koblarp Thongthong, Patama Bhurayanontachai, Pichai JirarattanasopaDepartment of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Hat yai, Songkhla Province, ThailandBackground: To evaluate photoreceptor disruption in patients with central serous chorioretinopat...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ratanasukon M, Thongthong K, Bhurayanontachai P, Jirarattanasopa P
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/ec3b1c3cfe3c4fdd8d2340eb9d5cffd1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
par: Sanguansak T, et autres
Publié: (2015)

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
par: Fujita K, et autres
Publié: (2012)

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
par: Alkin Z, et autres
Publié: (2014)

3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
par: Yu-Chen Hu, et autres
Publié: (2021)

Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy
par: Tsakonas GD, et autres
Publié: (2012)

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
par: Mohabati D, et autres
Publié: (2018)

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
par: Dhirani NA, et autres
Publié: (2017)

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy
par: Shimizu K, et autres
Publié: (2017)

Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment
par: Inoda S, et autres
Publié: (2019)

Low-dose aspirin as treatment for central serous chorioretinopathy
par: Antonio Caccavale, et autres
Publié: (2010)

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
par: Asahi MG, et autres
Publié: (2017)

Central Serous Chorioretinopathy: Pathogenesis and Management
par: Semeraro F, et autres
Publié: (2019)

Central serous chorioretinopathy: a pathogenetic model
par: et al, et autres
Publié: (2011)

Treatment of central serous chorioretinopathy with topical NSAIDs
par: Bahadorani S, et autres
Publié: (2019)

Transpupillary thermotherapy for atypical central serous chorioretinopathy
par: Kawamura R, et autres
Publié: (2012)

Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences
par: Ratanasukon M, et autres
Publié: (2018)

Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
par: Bhurayanontachai P, et autres
Publié: (2011)

Characteristics of intraretinal deposits in acute central serous chorioretinopathy
par: Plateroti AM, et autres
Publié: (2014)

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
par: Chin EK, et autres
Publié: (2015)

Navigated focal laser photocoagulation for central serous chorioretinopathy
par: Chhablani J, et autres
Publié: (2014)

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
par: Karim SP, et autres
Publié: (2013)

Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy
par: Ambiya V, et autres
Publié: (2016)

Predicting Central Serous Chorioretinopathy Recurrence Using Machine Learning
par: Fabao Xu, et autres
Publié: (2021)

Forgotten exogenous corticosteroid as a cause of central serous chorioretinopathy
par: Paul W Hardwig, et autres
Publié: (2008)

GRADED CRITERIA OF DIAGNOSTICS AND PREDICTION OF CENTRAL SEROUS CHORIORETINOPATHY OUTCOME
par: A. G. Shchuko, et autres
Publié: (2016)

Features of emotional and personality status of patients with central serous chorioretinopathy
par: A. A. Shchuko, et autres
Publié: (2016)

Factors affecting resolution of subretinal fluid after selective retina therapy for central serous chorioretinopathy
par: Akika Kyo, et autres
Publié: (2021)

In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy
par: Bazzazi N, et autres
Publié: (2015)

Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study
par: Doepfner JM, et autres
Publié: (2018)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
par: Mohabati D, et autres
Publié: (2020)

Modified Low Power Mode Laser for the Treatment of Central Serous Chorioretinopathy
par: Miura M, et autres
Publié: (2020)

Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
par: Abd Elhamid AH
Publié: (2015)

Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
par: Khatri A, et autres
Publié: (2018)

Persistent subretinal fluid due to central serous chorioretinopathy after retinal detachment surgery
par: Moreno-L&oacute;pez M, et autres
Publié: (2011)

Short wavelength automated perimetry and standard automated perimetry in central serous chorioretinopathy
par: Han Peng Zhou, et autres
Publié: (2020)

Evaluation of Psychophysiological and Hormonal Changes in Acute and Chronic Forms of Central Serous Chorioretinopathy
par: A. A. Shchuko, et autres
Publié: (2019)

Short Axial Length Is Related to Asymmetric Vortex Veins in Central Serous Chorioretinopathy
par: Nobuhiro Terao, MD, PhD, et autres
Publié: (2021)

Predictive factors of selective mineralocorticoid receptor antagonist treatment in chronic central serous chorioretinopathy
par: Róbert Gergely, et autres
Publié: (2020)

Multicolor imaging in central serous chorioretinopathy – a quantitative and qualitative comparison with fundus autofluorescence
par: Vishal Govindahari, et autres
Publié: (2019)

Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy
par: Te-An Wang, et autres
Publié: (2021)